Skip to main content
. 2017 Jul 27;117(6):840–847. doi: 10.1038/bjc.2017.235

Table 3. Clinicopathological variables related to sL1CAM status in preoperative blood samples from women treated for endometrial cancer.

  sL1CAM
Variable Low, n (%) High, n (%) P-value
Age (years)     <0.001
 <66 165 (89) 20 (11)  
 ⩾66 116 (62) 71 (38)  
Information available preoperatively
Curettage histologya     <0.001
 Low risk 217 (80) 54 (20)  
 High risk 58 (62) 36 (38)  
PR curettage     0.027
 Positive 160 (81) 37 (20)  
 Negative 37 (67) 18 (33)  
ER-α curettage     0.023
 Positive 157 (81) 37 (19)  
 Negative 38 (67) 19 (33)  
Information available postoperatively
FIGO-09 stage     <0.001
 I–II 252 (80) 61 (20)  
 III–IV 29 (49) 30 (51)  
Histologic type     <0.001
 Endometrioid 238 (80) 61 (20)  
 Adenosquamous 4 (100) 0 (0)  
 Clear cell 9 (75) 3 (25)  
 Serous papillary 18 (55) 15 (45)  
 Carcinosarcoma 10 (59) 7 (41)  
 Undifferentiated/other 2 (29) 5 (71)  
Histologic gradeb     0.95
 Grade 1/2 192 (80) 48 (20)  
 Grade 3 47 (80) 12 (20)  
Metastatic nodes     0.003
 Negative 225 (83) 44 (17)  
 Positive 22 (63) 13 (37)  
Myometrial infiltration     0.027
 <50% 175 (80) 42 (20)  
 ⩾50% 106 (71) 44 (29)  
Ploidy     0.15
 Diploid 145 (78) 42 (22)  
 Aneuploid 31 (67) 15 (33)  

Abbreviations: ER=oestrogen receptor; FIGO=Federation of Gynaecology and Obstetrics; PR=progesterone receptor; sL1CAM= soluble L1 cell adhesion molecule.

Missing information on curettage histology classification for 7 patients, PR status in curettage for 120 patients, ER-α status in curettage for 121 patients, grade for 4 patients, metastatic nodes for 68 patients, myometrial infiltration for 5 patients and ploidy for 139 patients.

a

Curettage histological risk classification, low risk (benign, hyperplasia or endometrioid grades 1–2) or high risk (non-endometrioid or endometrioid grade 3).

b

Only endometrioid.